About Peptide Works
About Peptide Works
A supplier of high-purity research peptides, independently tested and shipped worldwide to laboratories, universities, research groups, and independent researchers.
Peptide Works supplies high-purity, ready-to-use research peptides to laboratories, universities, private research groups, and independent researchers around the world. That single sentence explains what we are in the simplest possible terms. It does not, however, explain what we actually do each day, why the business is set up the way it is, or what a researcher can reasonably expect once an order is placed. This page is our answer to those questions.
Research supply is not a glamorous business. Nobody writes a paper about the vial. The vial simply has to be right. The right compound. The right weight. The right purity. Filled properly. Sealed properly. Labelled properly. Stored properly. Shipped properly. Documented properly. When all of that is correct, nobody gives it a second thought. When it is wrong, weeks of work can quietly disappear, and the person who loses that work usually finds out far too late to do anything about it.
Peptide Works was founded on that reality. Our role is to be the part of a research workflow that you never have to think about.
Peptide Works began the way most supply businesses begin. It began with frustration.
The people behind Peptide Works came from backgrounds where peptides were part of everyday work, and where the reagent supply chain was a constant source of irritation. Certificates of analysis were often generic, undated, or clearly carried over from an earlier production run. Purity figures were claimed for marketing purposes rather than measured for the batch in hand. Vials arrived warm after sitting in a depot over a weekend. Questions about a specific lot were answered by someone reading from a script who had no access to the lot data and no way of getting it.
None of these problems were dramatic. That is exactly what made them so persistent. On its own, each one was a small annoyance that a researcher could tolerate and work around. Together, they added unnecessary friction to work that was already difficult enough. They also chipped away at something that should be the baseline of the relationship, which is being able to trust the material in front of you without having to verify it all over again yourself.
What became Peptide Works started with a fairly simple question. What would a peptide supplier look like if it were designed by the people who have to use the product rather than by the people who have to sell it?
The answer, as it turned out, was not to chase a broad audience early on. We started with a lean catalogue, a small group of manufacturing partners, and a level of attention to verification and communication that many would consider excessive. These principles continue to shape how Peptide Works about us and how every new product or service is evaluated.
Verification meant that no batch entered our inventory on the strength of a supplier's word. Every lot was independently tested before we would list the product, and if the results did not meet our threshold, that lot was not sold. It was not discounted. It was not quietly blended into existing stock. It was rejected. That cost money in the early years and it still costs money today. We have never seriously considered changing it, because without it the rest of the company has nothing to stand on.
Communication meant that if a researcher wrote to us about a compound, a lot, or a handling issue, the reply came from someone who would go and look it up. Not a canned response. Not a link to a policy page. An answer.
The entire business was built on those two promises, and it still is. Everything since then, including a larger catalogue, new formats, and an international logistics network, has been added around them, and only once we were confident it would not knock them off balance.
The catalogue is considerably broader than it once was. We now offer a wide range of research peptides in several formats, we ship to most countries, and we use a network of independent laboratories for batch testing rather than relying on a single testing contract.
The business has grown, but the internal test has stayed the same. Before we add a compound, introduce a format, or enter a new market, we ask whether we can do it to the same standard as everything else we already supply. When the honest answer is no, we wait until it becomes yes. That has meant turning down opportunities that would have been good for short-term revenue. We believe it is also the reason researchers keep coming back.
Our mission is to support scientific discovery by supplying peptides of the highest quality, offering knowledgeable input, and delivering reliably around the world.
That is the formal version. Here is the working version we actually use inside the company.
The reagent should be the least interesting variable in the experiment.
When a researcher designs a study, their attention belongs on the hypothesis, the controls, the statistical power, and the interpretation. It does not belong on whether the vial contains what the label says it contains. When our work is done properly, that question never enters their mind, because we have already answered it, documented it, and made the evidence available before the vial ever reaches the bench.
Every operational decision at Peptide Works is measured against that standard. Does this improve the reliability of the material? Does this increase the trust a researcher can reasonably place in it? Does this reduce the chance of an unpleasant surprise? Anything that does not clear at least one of those three tests is not worth doing, no matter how well it might sell.
We want Peptide Works to be the supplier you reach for without stopping to think about it.
Trust of that kind cannot be bought with a campaign. It is built slowly and unevenly, through consistency. A researcher places one order and the material performs. Six months later, a second lot arrives and behaves exactly like the first. A difficult question is asked and receives a real answer rather than an evasion. A problem is raised and it is resolved rather than argued over. After enough of those interactions, the supplier stops being a decision and becomes a default.
That is what we are working towards. Not the largest range on the market. Not the loudest voice. Not the lowest price. Simply the supplier that researchers no longer have to think twice about.
Corporate writing tends to go quietly to sleep in the values section, so we have limited ours to the things that genuinely change what we do on an ordinary Tuesday.
We do not claim a purity we have not measured. We do not describe a compound in terms that go further than the evidence supports. We do not manufacture urgency, invent scarcity, or dress up a marketing position as a scientific one. When we do not know something, we say so, and where it is appropriate we go and find out, rather than pressing ahead and pretending otherwise.
The same applies internally. An employee who raises a concern about a batch, a shipment, or a process is doing their job, and it is recognised as such. The surest way to put a bad product in front of a researcher is to build a culture where raising the alarm feels inconvenient.
Every batch is an unknown quantity until it has been tested. Good results from a manufacturer in the past do not earn an exemption. Consistency does not remove the need for verification. Verification is what creates the confidence that consistency exists at all.
A certificate of analysis is only useful if it belongs to the material in the box. Our documentation is lot-specific. Where a researcher needs supporting detail for their own records, we would rather have the conversation than close it down.
Things do go wrong. Shipments are delayed. Packaging fails. People make mistakes. What matters is what happens next. Our position is simple. A problem we created is a problem we own, and the researcher affected by it should never have to fight to be heard.
A supplier who is occasionally excellent is not really a supplier at all. The value of what we do lies in repetition. The second lot should look like the first, and the twentieth should look like both.
Our catalogue covers a broad range of research peptides and related compounds, supplied in several formats so that they fit the different ways laboratory work is carried out. Researchers reviewing individual catalogue entries can also find product-specific information through listings such as Peptide Works 5-Amino-1MQ.
This is the standard presentation and still the one used most widely in research environments. Peptides are supplied as a lyophilised powder in sealed vials. This gives the best stability profile for storage and leaves the researcher in full control of reconstitution volume and buffer choice.
Vials are filled and sealed under controlled conditions. Each one is marked with a compound identifier, a nominal quantity, and a lot number that ties the vial back to its batch documentation.
Some research protocols call for defined combinations of compounds. These can be prepared individually, but doing so adds handling steps and further opportunities for error. Blends and stacks are made to defined compositions, so the ratio is fixed at the point of manufacture rather than at the bench.
Documentation is provided for each component. That gives the researcher full visibility of what is in the vial, rather than a proprietary formulation that cannot be inspected.
Some research work calls for a solid, capsule-based presentation of a compound. Researchers reviewing this format can see one catalogue example on the Peptide Works 5-Amino-1MQ page. Like everything else in the catalogue, capsule-based compounds are supplied and documented as laboratory research materials.
We supply prepared nasal spray formats for research applications that require an intranasal presentation. These involve additional formulation considerations, including the solvent system, the concentration, the stability of the compound in solution, and the metering characteristics of the delivery device. They are prepared and documented with those parameters in mind.
Pre-mixed pen formats are available where a reconstituted, metered presentation suits the research protocol. These carry different storage requirements from lyophilised material, and those requirements are stated clearly rather than buried in the small print.
We are often asked whether we can supply compounds that do not appear in the current listing. Sometimes the answer is yes. Sometimes the answer is no, either because we cannot source material we can stand behind, because we cannot verify it to a standard we would accept, or because supplying it would not be appropriate. Individual catalogue pages, including https://peptide-works.com/vilon/, are published only when we have a supply and verification route that meets the same standard applied across the catalogue. When we cannot meet that standard, we say no rather than accepting the order and hoping for the best. A supplier who never says no is not being helpful. They are simply moving the risk onto the customer without mentioning it.
This is the most important part of the business, so it is given the most space here.
Our catalogue standard is a minimum of 99% purity. For more complex sequences, which are harder to assemble and purify, the practical ceiling is lower, and our minimum for those is 98%.
We make that distinction deliberately, and we would rather explain it than hide it. Longer chains, difficult residues, compounds prone to aggregation, and sequences that require particular protecting-group strategies are simply harder to purify to the same level as short, well-behaved chains. When a supplier quotes an identical figure across a broad catalogue regardless of chemistry, they are either not measuring or not telling the whole story. Two honest thresholds are better than one convenient one.
Purity here means measured purity, on the specific batch, by an independent laboratory. It does not mean a theoretical figure supplied by the manufacturer, and it does not mean a historical figure carried over from an earlier production run.
Batches are assessed for identity and purity using analytical methods appropriate to the compound being tested. Identity confirmation establishes that the material is the intended sequence. Purity analysis establishes how much of the material is the compound itself and characterises what else is present.
If a batch falls below our threshold, it does not go on sale. It is not sold at a discount. It is not repackaged. It is not blended into a passing lot. It is rejected. The business absorbs that cost, and it is arguably the single most important thing we do.
Testing is carried out by a third-party laboratory with no stake in the result. This matters. A manufacturer testing its own output has an obvious conflict of interest, however honourable the people involved may be. Independent verification removes that conflict entirely.
We also avoid depending on a single testing relationship, because a single relationship is a single point of failure. Using more than one independent laboratory gives us a way to cross-check our own quality process, not just the material passing through it.
Lot-specific documentation accompanies every batch. The lot number on the vial links to the analysis of that lot, not to the compound in general and not to a previous production run.
If a researcher needs supporting analytical detail, whether for their own records, for a supervisor, for a compliance file, or for a methods section, we would rather provide it the first time than make them ask twice.
Purity at the point of manufacture is only part of the story. A peptide that leaves the laboratory at 99% purity and then sits at room temperature for a fortnight is no longer 99% pure, and no certificate can rescue it.
Rather than treating storage and handling as a separate logistics problem, we fold them into quality control and treat storage as quality at rest. Material is held under conditions appropriate to the compound. Where a peptide has particular sensitivities to temperature, light, or moisture, we pack, store, and document accordingly for the researcher receiving it.
We would far rather a researcher stores our material correctly and gets a clean result than stores it badly and blames the chemistry afterwards. So we state the conditions plainly, and we put them where people will actually see them.
People often picture a supplier as an operation that buys in bulk, splits the material into vials, and puts it on a shelf. Most of the real work happens between synthesis and dispatch, so it is worth walking through what actually happens to a batch during that time.
We do not synthesise every compound ourselves, and we have never claimed to. What we do control is who we work with, and on what terms.
Assessing a manufacturing partner takes time, and we have learned not to rush it. What interests us is not their capability in general, but how they synthesise and purify the specific class of compound in question. A facility with excellent accreditation and a strong record on short chains may still be the wrong choice for long or aggregation-prone sequences. Competence is compound-specific, and failing to recognise that is how suppliers end up with wildly uneven catalogues.
We pay particular attention to how a partner behaves when something goes wrong, rather than when everything goes right. That tells us far more. A manufacturer who tells us about an out-of-specification result before we find it ourselves is worth more than one with a spotless record who has simply become skilled at not mentioning things.
Material arriving from a manufacturing partner is not ready for sale. It goes into quarantine, and it stays there until it has been independently tested and has passed.
This is where most of our internal work happens, and it is where a supplier either has a quality process or simply has a claim about quality. Quarantine is inconvenient. It ties up capital, it slows restocking, and it sometimes means telling a researcher that a compound is out of stock while that very product sits on a shelf waiting for results. We hold the line anyway, because the alternative is to push verification onto the researcher instead.
Batches cleared from quarantine are tested by an external laboratory for identity and purity, using methods appropriate to the compound. Identity work confirms that the material is the sequence it is supposed to be. Purity work measures how much of the material is the compound and characterises what else is present.
The impurity profile matters as much as the headline number, and this is the part most marketing flattens. Two batches can share the same measured purity while carrying very different mixtures of impurities, and that difference can be significant or immaterial depending on what those impurities are. We would rather give the researcher the full picture than a single reassuring percentage.
If the results meet our pre-set threshold, the batch is released with a lot number and a documentation trail. If they do not, the batch is rejected.
People have occasionally asked why we do not simply sell sub-threshold material more cheaply with the analysis attached, and let the researcher decide for themselves. It is not an unreasonable question. Our answer is that once you begin selling material you have already judged to be below standard, the threshold stops being a threshold and becomes a suggestion. The internal pressure to reclassify a marginal batch as good enough for the cheaper option only grows from there. We would rather never be in that position at all.
Released material is filled and sealed under controlled conditions. Each unit carries its compound identifier, nominal quantity, and lot number, and it is stored under conditions suited to that compound.
Labelling looks trivial and is anything but. A vial whose lot number does not reliably lead back to the correct analysis is, for documentation purposes, an unidentified powder. The chain of traceability from vial to batch to certificate is one of the few things here that has to be perfect rather than merely good, and it is checked accordingly.
Only at this point does an order become a parcel. Packing decisions are made compound by compound rather than to a single house standard, because the requirements genuinely differ. An ambient-stable lyophilised powder and a pre-mixed pen with a cold-chain requirement are not the same logistical problem, and treating them as if they were is how material arrives technically intact but practically useless.
Our support team is not a call centre reading from a decision tree. When a researcher writes to us, the person who replies has access to batch data, product documentation, and shipping records, and understands what is being asked. Researchers looking for general information about products, storage, shipping, orders, payments, or returns can also review the Peptide Works FAQs.
The questions we receive are rarely about payment or delivery windows. They are about reconstitution and solvent compatibility. About storage in the laboratory and stability over time. About what a particular figure on a certificate actually means. About how to handle a compound that is behaving unexpectedly. These are serious technical questions from people doing real work, and they deserve serious technical answers.
There are limits, and we are open about them. We can tell you what is in the vial, how pure it was when tested, and how it should be stored and handled. We can discuss the physical and chemical properties of the material. We cannot design your experiment for you. We cannot interpret your results. We will not offer any suggestion regarding use in humans or animals. These boundaries are not evasion. They are the difference between a supplier being helpful and a supplier being dangerous.
Many suppliers treat delivery as the end of the relationship. We take the opposite view. Delivery is the moment our material enters the world, and it is therefore the moment questions are most likely to arise.
We would much rather hear that something is unclear, that the documentation is incomplete, or that a vial arrived in poor condition. Nothing is learned from a researcher who quietly writes us off and orders elsewhere. A researcher who tells us what went wrong gives us the chance to put it right, both for them and for everyone who orders after them.
We aim to reply quickly and we aim to reply accurately, and where those two goals conflict, accuracy wins. If we need to go back to a laboratory or check documentation we do not have in front of us, we will say so rather than invent an answer. When someone needs a decision about a batch, a fast wrong answer is far worse than a slightly slower correct one.
Peptide Works ships worldwide. The practical requirements of moving material vary considerably between academic institutions, commercial research groups, and independent laboratories, and we plan for that.
Packaging is not an afterthought here, because packaging is the last stage at which we can protect the integrity of the material.
Vials are packed to survive handling. They are protected against impact and vibration, shielded from light where the compound requires it, and protected from moisture where that matters. Where a compound needs temperature control in transit, it is shipped with insulation and cooling appropriate to the expected journey time.
When we pack an order, the question is not whether the parcel will look acceptable on arrival. The question is whether the contents will still meet specification when the researcher opens the box. Those are two different standards, and only one of them counts.
Orders are shipped with tracking, so the recipient is never left wondering where their material is.
We also offer shipping protection, because international logistics is genuinely unpredictable and no amount of careful packing removes the unexpected. Parcels are delayed. Parcels are mishandled. Occasionally parcels are lost outright. None of that is the researcher's fault, and shipping protection is our way of making sure they are not left paying for a failure in a network none of us control.
Goods that cross international borders are subject to the rules of those borders. Import regulations for research materials vary by jurisdiction, and they do not stay still.
Our position on this is deliberately plain. We will not pretend that customs clearance is seamless every time, because it is not, and a supplier who implies otherwise is simply setting their customer up for an unpleasant surprise. We will tell you what we know about shipping to your destination, provide the documentation the shipment requires, and be honest about anything we cannot guarantee.
Researchers and institutions remain responsible for confirming that any material they order can lawfully be imported into, and held for research in, their own jurisdiction. That responsibility is not ours to take on, and it would not serve our customers if we pretended otherwise.
We read "why choose us" sections with a certain amount of caution, because they tend to be a list of qualities every supplier claims. So rather than list the things we believe we do well, here is what customers actually tell us, in the words they tend to use.
This comes up more than anything else, and it is the point that matters most to people doing long-running work. Consistency between lots is not a sophisticated property, but it is the property that determines whether one result can be compared with the last. Researchers reorder from us because the second vial behaves like the first.
Independent laboratory testing, tied to a specific lot number, matching the material that arrives. It sounds like a low bar. It is not always met, which is precisely why researchers mention it.
Even when the honest answer is not the welcome one. If a compound is out of stock, we say so rather than taking the order and hoping. If a shipping route is unreliable, we say so before payment. If we cannot supply something to our standard, we say we cannot supply it.
A few customers have told us they found this off-putting at first, having grown used to suppliers who agree with everything. Most of them came back.
We are not the cheapest, and value is not the same thing as cheap. Rejecting failed batches costs money. Independent testing costs money. Proper cold-chain packaging costs money. Employing support staff who understand the chemistry costs money.
What that buys is a lower chance of a wasted experiment, and the arithmetic is not close. The cost of a vial is trivial next to the time, reagents, animal or cell resources, and staff hours invested in the work it supports. If saving a small amount on a reagent costs a month of work, no sensible researcher will make that trade twice.
A minimum of 99%, or 98% for complex sequences, tested independently on the batch. Not a slogan. A specification, with an explanation attached.
Worldwide shipping with protective packaging, tracking, and shipping protection, together with an honest account of what we can and cannot guarantee about the journey.
This is the part we want to be completely clear about, because ambiguity is where this industry has historically been at its weakest.
Peptide Works supplies laboratory research materials. That applies to every product without exception. They are intended for research and development use only, by people qualified to handle them, in an environment suited to research.
Our products are not intended for human consumption. They are not intended for animal consumption. They are not medicines, supplements, or cosmetics. We make no claims of any physiological, therapeutic, or aesthetic effect, and we will not begin making them, because doing so would be both wrong and irresponsible.
This is not boilerplate that we resent including. It reflects a genuine position. A supplier who knowingly nods in the direction of misuse, who describes research materials in consumer health language, who offers guidance they are not qualified to give, or who is happy for their claims to be read as something they are not, has decided that the risk belongs to somebody else. We reject that, and we do not operate that way.
If you are looking for a supplier who will support the use of research chemicals on yourself, we are not that company, and we would rather lose the sale than pretend otherwise.
We are a small operation for the size of our catalogue, and we see that as a strength rather than something to conceal.
The team is a mix of scientific and operational people, and the two groups spend a fair amount of time disagreeing with each other. That is intentional. The scientific instinct is to verify everything twice and move slowly. The operational instinct is to keep shelves stocked and parcels moving. The right answer is almost always somewhere between the two, and the only reliable way to find it is to have both arguments out loud.
Everyone here shares one trait, which is a low tolerance for vagueness. If a batch looks fine, the next question is what exactly was examined. If a shipping lane is generally reliable, the next question is what generally amounts to in practice. It can be tiring. It is also why our documentation stands up when a researcher looks at it closely.
We are also, deliberately, a company where the person answering a customer's question and the person who can go and check the record are either the same person or sitting a few feet apart. Preserving that closeness as we grow is a genuine priority. Once support becomes a department permanently disconnected from the data, the quality of the answers falls in a way that every customer notices, even if they cannot always name it.
People ask what we have planned, so here it is, without the usual vagueness.
We intend to keep expanding the catalogue, but guided by what can be verified rather than by what is in demand. Compounds are added only once we have a supply route we trust and a testing route that can verify it. We would rather be called slow than be called unreliable.
We intend to keep improving documentation. The reasoning is simple. Anyone who wants to interrogate our data should be able to, which means more analytical detail rather than less. A supplier whose material is good enough should be eager to make that easy.
We intend to keep extending shipping coverage responsibly, which means to destinations where the material can arrive in specification and where import is lawful. Where those two conditions are not met, we will continue to decline rather than dispatch and hope.
And we intend to remain exactly as careful with our claims. No therapeutic language. No implied uses we have no right to imply. No quiet drift into the consumer health framing that has caused so much damage in this space. Research supply, described as research supply.
It is not an especially thrilling vision. It is a commitment to doing the unglamorous work well, at scale, for a long time. In our experience, that is what researchers actually want from a supplier, and it is what suppliers most often fail to deliver.
Peptide Works exists to do one thing reliably. To give researchers a peptide that is exactly what it says it is, backed by documentation that proves it, packaged to survive the journey, and supported by people who can answer questions about it.
There is no clever positioning in that. It is simply the job, done properly, and repeated.
The work our customers do is difficult, expensive, and often thankless. It deserves reagents that are not one more thing to worry about. That is the standard we have set for ourselves, and it is the standard we expect to be held to.
All products on this website are for research use only. All products available on this website, and all products offered by Peptide Works, are intended for laboratory research and development only. These products are not intended for human or animal consumption or ingestion of any kind. All information, disclosures, and products on this website are provided for research or informational purposes only, and are not a substitute for professional advisory services that can assist with diagnosing any condition or treating any problem. The use, handling, storage, and importation of these materials are governed by the laws and regulations in force in the researcher's own jurisdiction and remain the sole responsibility of the researcher or institution.